What oseltamivir (Tamiflu) brands are available in the United States?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Oseltamivir Brands in the USA

Oseltamivir is available in the United States under the brand name Tamiflu, manufactured by Roche Pharmaceuticals, as well as generic formulations. 1, 2

Available Formulations

Brand Name Product (Tamiflu):

  • Capsules: 30 mg, 45 mg, and 75 mg 2, 3, 4
  • Oral Suspension: Powder for reconstitution to a final concentration of 6 mg/mL 2, 4

Generic Oseltamivir: Generic versions of oseltamivir became available in the United States and are therapeutically equivalent to the brand name Tamiflu 4, 5. These generic formulations are available in the same strengths and formulations as the brand name product.

Clinical Context

Oseltamivir remains the most commonly prescribed influenza antiviral in the United States, accounting for the vast majority of antiviral prescriptions during recent influenza seasons 5. Between 2016-2023, oseltamivir consistently represented the dominant share of influenza antiviral prescriptions among US insured individuals, with newer agents like baloxavir accounting for only 1.8%-9.2% of total prescriptions 5.

Important Prescribing Information

The commercially manufactured oral suspension is the preferred formulation for pediatric patients and adults who have difficulty swallowing capsules 2. If the commercial suspension is unavailable, pharmacies can compound a suspension from capsules using specific vehicles (Cherry Syrup, Ora-Sweet SF, or simple syrup) to achieve a final concentration of 6 mg/mL 2, 4.

During the 2022-2023 influenza season, there was a shortage of generic oseltamivir, prompting CDC recommendations to prioritize use for patients at greatest risk of influenza-related complications 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.